Enhancements    

PRODUCTION OF HUMAN RECOMBINANT MONOCLONAL RATTLESNAKE TOXIN-NEUTRALIZING ANTIBODY REAGENTS FOR DEVELOPING NOVEL ANTI-VENIN THERAPIES

PRODUCTION OF HUMAN RECOMBINANT MONOCLONAL RATTLESNAKE TOXIN-NEUTRALIZING ANTIBODY REAGENTS FOR DEVELOPING NOVEL ANTI-VENIN THERAPIES
PI: Jacen Moore
Sponsor: MARSH FOUNDATION
Clinical Lab Science
Amount awarded: $62,000

This project develops fully humanized antibodies to neutralize rattlesnake venom and circumvent the adverse effects of mild and serious reactions to animal-derived anti-venoms, which would halt the effects of envenomation, such as anaphylaxis and hypotension.

Posting date: Mon, 09/18/2017

Award start date: Fri, 09/01/2017
Award end date: Fri, 08/31/2018